GLP1R and diabetes mellitus: The individuals qualified as the J0/L0 group who had poor glycemic control at both V1 and V2, suffered from diabetes for a longer time, were treated with three or more oral (or GLP-1 agonist) antihyperglycemic agents and had previously problems with good glycemic control (a similar period in 2019).